Gene · 5890
Papers1,861
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,861
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-grade serous ovarian carcinoma organoids as models of chromosomal instability. | Elife | 2023 | 37166279 | PubTator, text mining | PubMed |
| Use of PARP inhibitors in prostate cancer: from specific to broader application. | Front Endocrinol (Lausanne) | 2023 | 37152924 | PubTator, text mining | PubMed |
| Germline DNA-Repair Genes and HOXB13 Mutations in Korean Men with Metastatic Prostate Cancer: Data from a Large Korean Cohort. | World J Mens Health | 2023 | 37118955 | PubTator, text mining | PubMed |
| Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score. | Breast | 2023 | 37116400 | PubTator, text mining | PubMed |
| Multi-organ landscape of therapy-resistant melanoma. | Nat Med | 2023 | 37106167 | PubTator, text mining | PubMed |
| Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature. | Thorac Cancer | 2023 | 37095004 | PubTator, text mining | PubMed |
| High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis. | J Immunother Cancer | 2023 | 37094985 | PubTator, text mining | PubMed |
| Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns. | Front Genet | 2023 | 37091785 | PubTator, text mining | PubMed |
| Next-generation sequencing study on poorly differentiated carcinoma derived from a thirty-year-old epidermoid cyst: A case report. | Front Oncol | 2023 | 37077824 | PubTator, text mining | PubMed |
| AAV-Mediated Gene Delivery to Mouse Brown Adipose Tissue. | Methods Mol Biol | 2023 | 37076680 | PubTator, text mining | PubMed |
| Somatic and germline aberrations in homologous recombination repair genes in Chinese prostate cancer patients. | Front Oncol | 2023 | 37064136 | PubTator, text mining | PubMed |
| Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients. | Med Oncol | 2023 | 37060468 | PubTator, text mining | PubMed |
| Nonspecific interactions between Cas12a and dsDNA located downstream of the PAM mediate target search and assist AsCas12a for DNA cleavage. | Chem Sci | 2023 | 37035707 | PubTator, text mining | PubMed |
| Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers. | Nat Commun | 2023 | 37029129 | PubTator, text mining | PubMed |
| Editorial: DNA methylation: The aging clock. | Front Cell Dev Biol | 2023 | 37009473 | PubTator, text mining | PubMed |
| BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib. | Front Oncol | 2023 | 37007122 | PubTator, text mining | PubMed |
| Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinoma. | J Pathol Clin Res | 2023 | 36999983 | PubTator, text mining | PubMed |
| Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. | Cancer Med | 2023 | 36999792 | PubTator, text mining | PubMed |
| A review of treatments targeting DNA-repair gene defects in metastatic castration resistant prostate cancer. | Front Oncol | 2023 | 36998466 | PubTator, text mining | PubMed |
| Personalized Systemic Therapies in Hereditary Cancer Syndromes. | Genes (Basel) | 2023 | 36980956 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5890/papers?page=13